Search results

Page results

• Study looking at whether COVID-19 and flu vaccines can be administered at the same time

  Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.

• UCLH top trust to work at in London – and third best in the country

  Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.

• Supporting young people with sickle cell at Tottenham Hotspur

  On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.

• Climate action and sustainability

  UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.

• First participant joins new Parkinson’s Disease study at UCLH

  UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.

• NHS Staff Survey 2024 – we’re the top acute trust to work at for third year running!

  Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!

• Trial of T-cell therapy for lung cancer begins at UCLH

  Trial of T-cell therapy for lung cancer begins at UCLH

• London hospitals partner up to run event for children and young people with sickle cell disorder at the Tottenham Hotspur Stadium

  North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.

• COVID-19 research studies rapidly opened at UCLH

  Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.

• World-first genotyping test that could transform care for people with sickle cell

  The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.